MoneyWorks4Me

Alembic Pharmaceuticals informs about disclosure

17 Jun 2024 Evaluate
Alembic Pharmaceuticals has informed that the company has received the USFDA Final approval for Icatibant Injection 30 mg/3mL (10 mg/mL) Single dose prefilled syringe. This is the first peptide product approval from the USFDA received by the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..